Monoamine oxidases: From brain maps to physiology and transgenics to pathophysiology

Journal of Neural Transmission, Supplement

Volumn , Issue 52, 1998, Pages 173-187

  Richards, J G ^a   Saura, J ^a   Luque, J M ^a   Cesura, A M ^a   Gottowik, J ^a   Malherbe, P ^a   Borroni, E ^a   Gray, J ^b  

^a F HOFFMANN LA ROCHE LTD   (Switzerland)

^b F HOFFMANN LA ROCHE LTD   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BRAIN MAPPING; CATALYSIS; HUMAN; HUMAN CELL; NERVE DEGENERATION; NONHUMAN; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RAT; TRANSGENIC ANIMAL; XENOBIOTIC METABOLISM; ALZHEIMER DISEASE; ANIMAL; BRAIN; ENZYMOLOGY; GENETICS; METABOLISM; MOUSE; PARKINSON DISEASE; PHYSIOLOGY; REVIEW; TRANSGENIC MOUSE;

AMINE OXIDASE (FLAVIN CONTAINING); FREE RADICAL; ISOENZYME;

ALZHEIMER DISEASE; ANIMALS; BRAIN; BRAIN MAPPING; FREE RADICALS; HUMANS; ISOENZYMES; MICE; MICE, TRANSGENIC; MONOAMINE OXIDASE; OXIDATIVE STRESS; PARKINSON DISEASE; RATS;

EID: 0031596730     PISSN: 03036995     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-3-7091-6499-0_17     Document Type: Article

References (52)

1. Abell CW, Stewart RM, Andrews PJ, Kwan S-W (1994) Molecular and functional properties of the monoamine oxidases. Heterocycles 39: 933-955
2. Adolfsson R, Gottfries CG, Oreland L, Wiberg A, Winblad B (1980) Increased activity of brain and platelet monoamine oxidase in dementia of Alzheimer type. Life Sci 27: 1029-1034
3. Anderson JK, Frim DM, Isacson O, Breakfield XO (1994) Catecholaminergic cell atrophy in a transgenic mouse aberrantly overexpressing MAO-B in neurons. Neurodegen 3: 97-109
4. Arnett CD, Fowler JS, MacGregor RR, Schlyer DJ, Wolf AP, Langstrom B, Halldin C (1987) Turnover of brain monoamine oxidase measured in vivo by positron emmission tomography using L-[11C]deprenyl. J Neurochem 49: 522-527
5. Cases O, Seif I, Grimsby J, Gaspar P, Chen K, Pournin S, Muller U, Aguet M, Babinet C, Shih JC, De Maeyer E (1995) Aggressive behavior and altered amounts of serotonin and norepinephrine in mice lacking MAO-A. Science 268: 1763-1766
6. Cesura AM, Pletscher A (1992) The new generation of monoamine oxidase inhibitors. Prog Drug Res 38: 171-297
7. Chan-Palay V, Hochli M, Savaskan E, Hungerecker G (1993) Calbindin D-28k and monoamine oxidase A immunoreactive neurons in the nucleus basalis of Meynert in senile dementia of the Alzheimer type and Parkinson's disease. Dementia 4: 1-15
8. Cohen G (1986) Monoamine oxidase, hydrogen peroxide and Parkinson's disease. Adv Neurol 45: 119-125
9. Damier P, Kastner A, Agid Y, Hirsch EC (1996) Does monoamine oxidase type B play a role in dopaminergic nerve cell death in Parkinson's disease? Neurology 46: 1262-1269
10. Da Prada M, Pieri L, Cesura AM, Kettler R (1994a) The pharmacology of moclobemide. Revs Contemp Pharmacol 5: 1-18
11. R, New Avenues", Berlin, October 1993. Editiones Roche, Basel, pp 99-117
12. Desagher S, Glowinski J, Premont J (1996) Astrocytes protect neurons from hydrogen peroxide toxicity. J Neurosci 16: 2553-2562
13. Fowler CJ, Wiberg A, Oreland L, Marcusson J, Winblad B (1980) The effect of age on the activity and molecular properties of human brain monoamine oxidase. J Neural Transm 49: 1-20
14. Fowler JS, Volkow ND, Wang G-J, Pappas N, Logan J, MacGregor R, Alexoff D, Shea C, Schyler D, Wolf AP, Warner D, Zezulkova I, Cilento R (1996) Inhibition of monoamine oxidase B in the brains of smokers. Nature 379: 733-736
15. Gerlach M, Ben-Shachar D, Riederer P, Youdim MBH (1994) Altered brain metabolism of iron as a cause of neurodegenerative diseases? J Neurochem 63: 793-807
16. Girman AS, Baenziger J, Hotamisligil GS, Konradi C, Shalish C, Sullivan JL, Breakfield XO (1992) Relationship between platelet monoamine oxidase B activity and alleles at the MAO-B locus. J Neurochem 59: 2063-2066
17. Goridis C, Neff NH (1971) Monoamine oxidase: an approximation of turnover rates. J Neurochem 18: 1673-1682
18. Goridis C, Neff NH (1973) Neuronal and hormonal influences on the turnover of monoamine oxidase in salivary gland. Biochem Pharmacol 22: 2501-2510
19. Gottfries CG, Adolfsson R, Aquilonius S-M, Carlsson A, Eckernas S-A, Nordberg A, Oreland L, Svennerholm L, Wiberg A, Winblad B (1983) Biochemical changes in dementia disorders of Alzheimer type (AD/SDAT). Neurobiol Aging 4: 261-271
20. Haefely W, Burkard WP, Cesura AM, Kettler R, Lorez HP, Martin JR, Richards JG, Scherschlicht R, Da Prada M (1992) Biochemistry and pharmacology of moclobemide, a prototype RIMA. Psychopharmacology 106: S6-S14
21. Jarman J, Glover V, Sandler M, Turjanski N, Stern G (1993) Platelet monoamine oxidase B activity in Parkinson's disease: a re-evaluation. J Neural Transm [P-D Sect] 5: 1-4
22. Konradi C, Svoma E, Jellinger K, Riederer P, Denney P, Thibault J (1988) Topographical immunocytochemical mapping of MAO-A, MAO-B and tyrosine hydroxylase in human post-mortem brainstem. Neuroscience 26: 791-802
23. Konradi C, Kornhuber J, Froelich L, Fritze J, Heinsen H, Beckmann H, Schulz E, Riederer P (1989) Demonstration of monoamine oxidase -A and -B in the human brainstem by a histochemical technique. Neuroscience 33: 383-400
24. Kurth JH, Kurth MC, Poduslo SE, Schwankhaus JD (1993) Association of a monoamine oxidase B alle with Parkinson's disease. Ann Neurol 33: 368-372
25. Luque JM, Kwan S-W, Abell CW, Da Prada M, Richards JG (1995) Cellular expression of mRNAs encoding monoamine oxidases A and B in the rat central nervous system. J Comp Neurol 363: 665-680
26. Luque JM, Bleuel Z, Hendrickson A, Richards JG (1996) Detection of MAO-A and MAO-B mRNAs in monkey brainstem by cross-hybridization with human oligonucleotide probes. Mol Brain Res 36: 357-360
27. Moll G, Moll R, Riederer P, Gsell W, Heinsen H, Denney RM (1990) Immunofluorescence cytochemistry on thin frozen sections of human substantia nigra for staining of monoamine oxidase A and monoamine oxidase B, a pilot study. J Neural Transm [Suppl] 32: 67-77
28. Nakamura S, Kawamata T, Akiguchi I, Kameyama M, Nakamura N, Kimura H (1990) Expression of monoamine oxidase B activity in astrocytes of senile plaques. Acta Neuropathol 80: 319-325
29. Nakamura S, Akigachi I, Kimura J (1993) A subpopulation of mouse striatal cholinergic neurons show monoamine oxidase activity. Neurosci Lett 161: 141-144
30. Nakamura S, Akigachi I, Kimura J (1995) Topographic distribution of monoamine oxidase-B -containing neurons in the mouse striatum. Neurosci Lett 184: 29-31
31. Nelson DL, Herbet A, Glowinski J, Hamon M (1979) [3H]Harmaline as a specific ligand of MAO-A. II. Measurement of the turnover rates of MAO A during ontogenesis in rat brain. J Neurochem 32: 1829-1836
32. Olanow CW (1993) A radical hypothesis for neurodegeneration. Trends Neurosci 16: 439-444
33. 3H]Ro 41-1049 binding to monoamine oxidase-A in the locus coeruleus is not altered in major depression. Soc Neurosci Abstr 368.2
34. Oreland L, Gottfries CG (1986) Brain monoamine oxidase in aging and in dementia of Alzheimer type. Prog Neuropsychopharmacol Biol Psychiatry 10: 533-540
35. Oreland L, Jossan SS, Hartvig P, Aquilonius SM, Langstrom B (1990) Turnover of monoamine oxidase B (MAO-B) in pig brain by positron emission tomography using 11C-L-deprenyl. J Neural Transm [Suppl] 32: 55-59
36. Parkinson Study Group (1993) A controlled trial of lazabenmide (Ro 19-6327) in untreated Parkinsons disease. Ann Neurol 33: 350-356
37. Reinikainen KJ, Paljarvi L, Halonen T, Malminen O, Kosma V-M, Laakso M, Riekkinen PJ (1988) Dopaminergic system and monoamine oxidase-B activity in Alzheimer's disease. Neurobiol Aging 9: 245-252
38. Robinson DS (1975) Changes in monoamine oxidase and monoamines with human development and aging. Fed Proc 34: 103-107
39. 3H-Ro 19-6327 in vitro: localization and abundance of MAO-A and MAO-B in rat CNS, peripheral organs, and human brain. J Neurosci 12: 1977-1999
40. Saura J, Luque JM, Cesura AM, Da Prada M, Chan-Palay V, Huber G, Loffler J, Richards JG (1994a) Increased monoamine oxidase -B activity in plaque-associated astrocytes of Alzheimer brains revealed by quantitative enzyme radioautography. Neuroscience 62: 15-30
41. Saura J, Richards JG, Mahy N (1994b) Differential age-related changes of MAO-A and MAO-B in mouse brain and peripheral organs. Neurobiol Aging 15: 399-408
42. Saura J, Bleuel Z, Ulrich J, Mendelowitsch A, Chen K, Shih JC, Malherbe P, Da Prada M, Richards JG (1996) Molecular neuroanatomy of human monoamine oxidases A and B revealed by quantitative enzyme radioautography and in situ hybridization histochemistry. Neuroscience 70: 755-774
43. Saura J, Andres N, Andrade C, Ojuel J, Eriksson K, Mahy N (1997) Biphasic and region-specific MAO-B response to aging in control human brain. Neurobiol Aging (in press)
44. Sparks DL, Woeltz VM, Markesbery WR (1991) Alterations in brain monoamine oxidase activity in aging, Alzheimer's disease, and Pick's disease. Arch Neurol 48: 718-721
45. Stevenson GB, Sturman SG, Heafield MTE (1989) Platelet monoamine oxidase B activity in Parkinson's disease. J Neural Transm 1: 255-261
46. Strolin-Benedetti M, Dostert P (1992) Monoamine oxidase: from physiology and pathophysiology to the design and clinical applications of reversible inhibitors. Adv Drug Res 23: 65-125
47. Waldmeier PC (1987) Amine oxidases and their endogenous substrates (with special reference to monoamine oxidase and the brain). J Neurotransm [Suppl] 23: 55-72
48. Westlund KN, Denney RM, Kochersperger LM, Rose RM, Abell CW (1985) Distinct monoamine oxidase A and B populations in primate brain. Science 230: 181-183
49. Westlund KN, Denney RM, Rose RM, Abell CW (1988) Localization of distinct monoamine oxidasde A and monoamine oxidase B cell populations in human brainstem. Neuroscience 25: 439-456
50. Yankner BA (1996) Mechanisms of neuronal degeneration in Alzheimer's disease. Neuron 16: 921-932
51. Youdim MBH (1995) The advent of selective monoamine oxidase A inhibitor antidepressants devoid of the cheese reaction. Acta Psychiatr Scand 91 [Suppl 386]: 5-7
52. Zetsche T, Chan-Palay V (1992) MAO-A and MAO-B immunoreactivity in the hippocampus, temporal cortex and cerebellum of normal controls and of patients with senile dementia of the Alzheimer type. Dementia 3: 270-281